Transforming Healthcare from Atom to Access: Q&A with NPG Health and Bliss Bio Health CEO Gloria Vanderham
The Next Practices Group and The Bliss Group are introducing a new healthcare platform, NPG Health and our first firm, Bliss Bio Health, that will...
Find out more >
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
Convalescent Plasma A 2022 New England Journal of Medicine article co-authored by The Bliss Group’s Managing Partner Michael Roth and Colin Foster, President of The Next Practice, details a...
Find out more >The Unfinished Business of Healthcare
The healthcare industry is a deeply personal place to work. More than 95 percent of the world’s population has health problems. An average of 1,905 people will die...
Find out more >
Unlocking Clinical Trial Recruitment in the COVID-19 Era
It’s nearly impossible to identify a facet of our healthcare industry that hasn’t been directly impacted by the COVID-19 pandemic. It follows that the vast...
Find out more >
At the Intersect (Series) – Spotlight on Healthcare
In our May post, we wrote that a disproportionate amount of innovation (and competition) is happening at the intersection of healthcare, financial services, retail and...
Find out more >Michael Roth Shares Insights: “WebMD’s Cold and Flu Map Is an Effective Marketing Tool – So Why Does It Make Some People Queasy?” ADWEEK
“WebMD’s Cold and Flu Map Is an Effective Marketing Tool –So Why Does It Make Some People Queasy?” ADWEEK
Find out more >